Charles A. Baker, Director at PROGENICS PHARMACEUTICALS INC (PGNX), sold 2,500 shares at $30.02 ($75K) on 2007-01-29, disclosed to the SEC on 2007-01-31.
Scheduled sale ($75k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2015-09-18 | $2.8M | — | Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |